Attend Our 15-Minute Ask the Expert Webcast on Purification of Large Molecule Therapeutics
Join us to learn how CHT™ Ceramic Hydroxyapatite XT Media can simplify the purification of monoclonal antibodies, antibody fragments, Fc-fusion proteins, and other large molecule therapeutics at research scale. Discover how it can improve aggregate removal, increase purity and throughput, and reduce sample loss compared to traditional polishing methods such as size-exclusion and cation-exchange chromatography.
Ask the Expert: Accelerating Purification of Large Molecule Therapeutics at Research Scale with a Hydroxyapatite Mixed-Mode Resin
Tuesday
8 AM PT | 11 AM EDT | 5 PM CEST
Learn how mixed-mode resins can simplify and accelerate the purification of antibody-based therapeutics and other large molecules at research scale. Discover how they improve aggregate removal, increase purity and recovery, and help overcome challenges associated with conventional polishing methods.
Key Takeaways
- CHT XT Mixed-Mode Media streamlines purification of large molecule therapeutics, offering efficient removal of aggregation and other contaminants
- The resin can mitigate risks associated with other polishing steps that can result in sample loss, low recovery, or reduced purity
About the Presenter
Ian Scott
Scientist, Protein Therapeutics
Gilead Sciences
Ian Scott is a research scientist and member of the Protein Therapeutics team at Gilead Sciences. He has more than 15 years of experience in protein purification, focusing on multi-specific antibodies, Fc-fusion proteins, antibody fragments, and other challenging proteins.